CVMP opinions on veterinary medicinal products

The Committee adopted by consensus a positive opinion for a marketing authorisation from Axience for Hemosyvet(etamsylate) for prevention and treatment of surgical, post traumatic, obstetric and gynaecological haemorrhages in cattle, sheep, goats, pigs, horses, dogs and cats.

The Committee adopted by consensus a positive opinion for a marketing authorisation from FILAVIE for Cevac REOMUNE for passive immunisation of broilers induced by active immunisation of broiler breeders to reduce clinical signs of tenosynovitis induced by avian reovirus infection.

The Committee adopted by consensus a positive opinion for a variation requiring assessment for Syvazul BTV 3 (Bluetongue virus, serotype 3, strain BTV-3/NET2023, inactivated) to add cattle as target species, and to increase of the minimum specification for antigen content in the finished product.

The Committee adopted by consensus a revised positive opinion for a worksharing variation…